ZA200809622B - A composition useful as a vaccine - Google Patents

A composition useful as a vaccine

Info

Publication number
ZA200809622B
ZA200809622B ZA200809622A ZA200809622A ZA200809622B ZA 200809622 B ZA200809622 B ZA 200809622B ZA 200809622 A ZA200809622 A ZA 200809622A ZA 200809622 A ZA200809622 A ZA 200809622A ZA 200809622 B ZA200809622 B ZA 200809622B
Authority
ZA
South Africa
Prior art keywords
vaccine
composition useful
useful
composition
Prior art date
Application number
ZA200809622A
Other languages
English (en)
Inventor
Ella Krishna Murthy
Gutla Victor Jerusha Augustus Harshavardhan
Vadrevu Krishna Mohan
Singhania Smita
Original Assignee
Bharat Biotech Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Biotech Int Ltd filed Critical Bharat Biotech Int Ltd
Publication of ZA200809622B publication Critical patent/ZA200809622B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
ZA200809622A 2006-05-12 2008-11-11 A composition useful as a vaccine ZA200809622B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN842CH2006 2006-05-12

Publications (1)

Publication Number Publication Date
ZA200809622B true ZA200809622B (en) 2009-07-29

Family

ID=38578478

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200809622A ZA200809622B (en) 2006-05-12 2008-11-11 A composition useful as a vaccine

Country Status (8)

Country Link
US (1) US9642907B2 (es)
CN (1) CN101489587B (es)
AU (1) AU2007251122B2 (es)
BR (1) BRPI0711608B8 (es)
GB (1) GB2451216B (es)
MX (1) MX2008014391A (es)
WO (1) WO2007132480A2 (es)
ZA (1) ZA200809622B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9598676B2 (en) * 2009-07-13 2017-03-21 Bharat Biotech International Limited Composition useful as rotavirus vaccine and a method therefor
US10092640B2 (en) * 2011-01-05 2018-10-09 Bharat Biotech International Limited Combination heptavalent vaccine
WO2013105105A2 (en) * 2012-01-13 2013-07-18 Serum Institute Of India Ltd. Novel viral vaccine compositions and methods for preparing such vaccines
CN104507495A (zh) * 2012-04-23 2015-04-08 巴拉特生物技术国际有限公司 轮状病毒疫苗组合物及其制备方法
WO2014032082A1 (en) * 2012-08-27 2014-03-06 Murdoch Childrens Research Institute Modified human rotaviruses and uses therefor
US9480739B2 (en) * 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
AR097762A1 (es) * 2013-09-27 2016-04-13 Intervet Int Bv Formulaciones secas de vacunas que son estables a temperatura ambiente
CN105530955A (zh) * 2013-10-03 2016-04-27 日东电工株式会社 流感疫苗干燥制剂、及流感疫苗干燥制剂的制造方法
SG11201610921PA (en) * 2014-07-18 2017-02-27 Msd Wellcome Trust Hilleman Lab Pvt Ltd A thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof
TWI745278B (zh) 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物
WO2017056101A1 (en) * 2015-09-30 2017-04-06 Panacea Biotec Limited Stable live attenuated recombinant dengue vaccine
GB201608323D0 (en) * 2016-05-12 2016-06-29 Ucb Biopharma Sprl Pharmaceutical compositions
MA44557B1 (fr) 2016-06-16 2021-11-30 Bharat Biotech Int Ltd Vaccin contre le rotavirus sans tampon, stable en milieu acide, et d'un faible volume de dose à administrer
GB201614799D0 (en) * 2016-09-01 2016-10-19 Glaxosmithkline Biologicals Sa Compositions
MY191286A (en) 2017-02-14 2022-06-14 Inventprise Llc Heat stable liquid rotavirus vaccine
US11110163B2 (en) 2017-02-14 2021-09-07 Inventprise, Llc Heat stable vaccines
CN108434106B (zh) * 2017-04-25 2021-07-30 广州瑞贝斯药业有限公司 一种狂犬病疫苗的冻干制剂
CN110055225A (zh) * 2018-01-18 2019-07-26 北京依生兴业科技有限公司 一种提高轮状病毒产量的方法
CN113994925B (zh) * 2021-12-30 2022-04-26 北京赛尔富森生物科技有限公司 一种轮状病毒攻毒动物模型及其建立方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629399A (en) * 1967-09-05 1971-12-21 Behringwerke Ag Stable poliomyelitis vaccines
SE445466B (sv) * 1977-12-01 1986-06-23 Wellcome Found Sett att foroka rotavirus in vitro
ATE171208T1 (de) * 1990-07-26 1998-10-15 Wistar Inst Impfstoff aus reassortiertem rotavirus
US5773009A (en) 1994-04-15 1998-06-30 The United States Of America As Represented By The Department Of Health And Human Services Rotavirus strain G9P11
AU3125795A (en) * 1994-07-11 1996-02-09 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Attenuated human rotavirus vaccine
US6616931B1 (en) * 1996-09-26 2003-09-09 Merck & Co., Inc. Rotavirus vaccine formulations
US5932223A (en) * 1996-09-26 1999-08-03 Merck & Co., Inc. Rotavirus vaccine formulations
US6290967B1 (en) * 1996-12-20 2001-09-18 Merck & Co., Inc. Stabilizers for lyophilized vaccines
US6210683B1 (en) * 1997-09-05 2001-04-03 Merck & Co., Inc. Stabilizers containing recombinant human serum albumin for live virus vaccines
FR2791895B1 (fr) * 1999-03-23 2001-06-15 Pasteur Merieux Serums Vacc Utilisation de trehalose pour stabiliser un vaccin liquide
AU2356002A (en) * 2000-09-25 2002-04-02 Polymun Scient Immunbio Forsch Live vaccine and method of manufacture
AU2004299057B2 (en) 2003-12-17 2010-06-24 Wyeth Llc Methods for porducing storage stable viruses and immunogenic compositions thereof
DK1833508T3 (da) * 2004-11-19 2010-12-06 Intervet Int Bv Virusstammer og sammensætninger af PRRS-syndromet (porcint reproduktivt og respiratorisk syndrom)
GB0503337D0 (en) * 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
WO2007035455A2 (en) * 2005-09-16 2007-03-29 Merial Limited Stabilizers for freeze-dried vaccines
CA2628084A1 (en) * 2005-11-01 2007-05-10 Novartis Ag Compositions with antigens adsorbed to calcium phosphate

Also Published As

Publication number Publication date
BRPI0711608A2 (pt) 2012-08-14
BRPI0711608B1 (pt) 2019-08-20
GB0821386D0 (en) 2008-12-31
US9642907B2 (en) 2017-05-09
BRPI0711608B8 (pt) 2021-05-25
AU2007251122A1 (en) 2007-11-22
CN101489587A (zh) 2009-07-22
GB2451216B (en) 2011-05-04
CN101489587B (zh) 2015-05-27
WO2007132480A2 (en) 2007-11-22
US20100068227A1 (en) 2010-03-18
GB2451216A (en) 2009-01-21
WO2007132480A3 (en) 2008-03-20
MX2008014391A (es) 2009-03-06
AU2007251122B2 (en) 2013-01-10
WO2007132480B1 (en) 2008-05-22

Similar Documents

Publication Publication Date Title
ZA200809622B (en) A composition useful as a vaccine
IL227934A0 (en) Immunogenic preparation
GB0607088D0 (en) Vaccine
GB0623838D0 (en) Novel compositions
ZA200709518B (en) Vaccine composition
GB0607085D0 (en) Novel compositions
EP2018182A4 (en) IMMUNOGENIC COMPOSITIONS
HK1129836A1 (zh) 疫苗
ZA200903656B (en) Novel composition
GB0606416D0 (en) Immunogenic composition
GB0701048D0 (en) A composition
GB0621329D0 (en) Novel composition
ZA200901592B (en) Vaccine
GB0917779D0 (en) Novel compositions
GB0606856D0 (en) Vaccine compositions
GB0625593D0 (en) Vaccine
GB0602761D0 (en) Vaccine Composition
GB0606417D0 (en) Immunogenic composition
GB0702363D0 (en) Vaccine composition
GB0606256D0 (en) Anti-atheroma vaccine
GB0619826D0 (en) Vaccine
GB0620815D0 (en) Vaccine
GB0619820D0 (en) Vaccine
GB0620337D0 (en) Vaccine
GB0620816D0 (en) vaccine